Biotricity ROE 2015-2025 | BTCY
Current and historical return on equity (ROE) values for Biotricity (BTCY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Biotricity ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.01B | $-0.03B | 38.40% |
| 2024-12-31 | $-0.01B | $-0.03B | 45.16% |
| 2024-09-30 | $-0.02B | $-0.03B | 53.33% |
| 2024-06-30 | $-0.02B | $-0.03B | 62.07% |
| 2024-03-31 | $-0.02B | $-0.03B | 55.05% |
| 2023-12-31 | $-0.02B | $-0.03B | 65.31% |
| 2023-09-30 | $-0.02B | $-0.03B | 84.71% |
| 2023-06-30 | $-0.02B | $-0.02B | 110.14% |
| 2023-03-31 | $-0.02B | $-0.02B | 150.94% |
| 2022-12-31 | $-0.02B | $-0.02B | 240.00% |
| 2022-09-30 | $-0.02B | $-0.01B | 511.11% |
| 2022-06-30 | $-0.03B | $-0.01B | -11600.00% |
| 2022-03-31 | $-0.03B | $0.00B | 4000.00% |
| 2021-12-31 | $-0.03B | $0.00B | 1500.00% |
| 2021-09-30 | $-0.03B | $0.01B | 514.29% |
| 2021-06-30 | $-0.02B | $-0.01B | 211.11% |
| 2021-03-31 | $-0.02B | $-0.01B | 213.33% |
| 2020-12-31 | $-0.02B | $-0.01B | 230.77% |
| 2020-09-30 | $-0.01B | $-0.01B | 305.88% |
| 2020-06-30 | $-0.01B | $-0.01B | 320.00% |
| 2020-03-31 | $-0.01B | $0.00B | 440.00% |
| 2019-12-31 | $-0.01B | $0.00B | 355.56% |
| 2019-09-30 | $-0.01B | $-0.01B | 457.14% |
| 2019-06-30 | $-0.01B | $0.00B | 1600.00% |
| 2019-03-31 | $-0.01B | $0.00B | 1600.00% |
| 2018-12-31 | $-0.01B | $0.00B | 0.00% |
| 2018-09-30 | $-0.01B | $0.00B | 0.00% |
| 2018-06-30 | $-0.01B | 0.00% | |
| 2018-03-31 | $-0.01B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.012B | $0.014B |
| Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.919B | 58.42 |
| Doximity (DOCS) | United States | $11.317B | 52.39 |
| Hims & Hers Health (HIMS) | United States | $10.654B | 110.70 |
| Tempus AI (TEM) | United States | $10.042B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.327B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.691B | 57.67 |
| Hinge Health (HNGE) | United States | $3.687B | 0.00 |
| Privia Health (PRVA) | United States | $2.458B | 168.00 |
| Schrodinger (SDGR) | United States | $1.674B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.583B | 0.00 |
| Phreesia (PHR) | United States | $1.580B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.38 |
| Azenta (AZTA) | United States | $1.434B | 66.64 |
| 10x Genomics (TXG) | United States | $1.421B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Evolent Health (EVH) | United States | $1.146B | 97.60 |
| Claritev (CTEV) | United States | $0.705B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.540B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.479B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.465B | 0.00 |
| Talkspace (TALK) | United States | $0.427B | 127.50 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.310B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| CapsoVision (CV) | United States | $0.206B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.187B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
| Pulmonx (LUNG) | United States | $0.128B | 0.00 |
| American Well (AMWL) | United States | $0.125B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |